SP5B Astrotech Corp

Astrotech Subsidiary 1st Detect Appoints Raj Mellacheruvu as President and Chief Executive Officer

Astrotech subsidiary 1st Detect is very pleased to announce the appointment of Raj Mellacheruvu as President and Chief Executive Officer (CEO), effective immediately. Former CEO Thomas B. Pickens III will continue to serve in his role as Chairman of the Board. Mr. Mellacheruvu has spent his career commercializing innovative technologies in both start-up and large enterprise environments. Most recently he served as the Vice President and Chief Operating Officer of 1st Detect and was instrumental in revolutionizing the Explosives Trace Detection (ETD) market with the introduction of an ETD-based on mass spectrometry technology. Prior to that, he was the Managing Director of Noumenon Consulting, Inc., providing consulting services on product strategy, management, and business operations. Mr. Mellacheruvu was previously employed by ClearCube Technology, Inc., Omega Band, and Advanced Micro Devices.

Mr. Mellacheruvu has an MBA in Business Strategy and Finance from Kellogg School of Management at Northwestern University, a Master’s degree in Electrical Engineering from Texas A&M University, and a Bachelor’s degree in Electronics and Communication Engineering from Osmania University.

Thomas B. Pickens III, Chairman and CEO of Astrotech (NASDAQ: ASTC) and Chairman of 1st Detect, added, “We are very pleased to have Raj in his new role as CEO as he leads 1st Detect forward in the adoption of the TRACER 1000™ by airports worldwide.”

Mr. Mellacheruvu commented, “I am honored to assume this new role and I am excited to drive the development and execution of our corporate strategy going forward. Our core market of aviation security has, at best, seen incremental improvements in Explosives Trace Detection over the last few decades. We are excited to introduce our ETD technology that pays for itself in under a year while providing the best in protection from evolving terroristic threats.”

About Astrotech Corporation

Astrotech (NASDAQ: ASTC) is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value. 1st Detect develops, manufactures, and sells chemical analyzers for use in the security, defense, healthcare, and environmental markets. Astral Images sells film-to-digital image enhancement, defect removal, color correction, and post processing software, providing economically feasible conversion of film to the new 4K ultra-high definition (UHD), high-dynamic range (HDR) format. Astrotech is headquartered in Austin, Texas. For information, please visit .

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the Company’s use of proceeds from the private placement transaction, whether we can successfully develop our proprietary technologies and whether the market will accept our products and services, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the annual report on Form 10-K for the fiscal year ended June 30, 2018. Any forward-looking statements in this document should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to update these forward-looking statements.

EN
19/02/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Astrotech Corp

 PRESS RELEASE

Astrotech Announces Date for Fiscal Year 2022 Annual Meeting and Deadl...

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation (Nasdaq: ASTC) (the “Company”) announced its plans to hold its fiscal year 2022 annual meeting of stockholders (the “2022 Annual Meeting”) on Tuesday, November 15, 2022. The 2022 Annual Meeting will be held at 9:00 a.m. Central Time. Current plans are for the meeting to be in person in Austin, Texas at the Company’s main office. The Company anticipates sending proxy materials for the annual meeting to stockholders in September 2022. Astrotech Corporation 2022 Annual Meeting of Stockholders Astrotech Corporation Main Office 2105 Donley Dri...

 PRESS RELEASE

Astrotech Appoints Jim Becker to Board of Directors

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation (Nasdaq: ASTC) announced today that it has appointed Jim Becker to its Board of Directors. Mr. Becker brings to Astrotech’s Board extensive leadership, with a focus on strategic market growth and expansion, and business process improvements and scaling, along with public speaking and corporate management skills. He will serve on each of the compensation committee, the corporate governance and nominating committee, and the audit committee of the Board of Directors. Mr. Becker stated, “I look forward to joining the Board of Astrotech. With ...

 PRESS RELEASE

Astrotech Subsidiary and Cleveland Clinic Expand Breath Analysis Study...

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation’s (NASDAQ: ASTC) subsidiary, BreathTech Corporation, announced today that it has amended its Joint Development and Option Agreement with Cleveland Clinic to include additional areas of focus. Under the amended agreement, ongoing work around development of a rapid breath test for COVID-19 will be expanded to utilize BreathTech’s core mass spectrometry technology to screen for a variety of diseases spanning the entire body. The project will focus on detecting bloodstream infections, respiratory infections such as influenza types A and B and ...

 PRESS RELEASE

Astrotech Reports Third Quarter of Fiscal Year 2022 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the third quarter of fiscal year 2022, which ended March 31, 2022. Astrotech's subsidiary 1st Detect continues sales of its TRACER 1000™ solution, the first and only mass spectrometry-based explosives trace detector (ETD) certified by the European Civil Aviation Conference (ECAC) for air and cargo security, with revenue related to the TRACER 1000 up 161% to $845 thousand for the nine months ended March 31, 2022, compared to the same period one year ago. The T...

 PRESS RELEASE

Astrotech Reports Second Quarter of Fiscal Year 2022 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)-- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the second quarter of fiscal year 2022, which ended December 31, 2021. Astrotech had its best quarter since sales of 1st Detect’s TRACER 1000™ began, with revenue related to the TRACER 1000 up 332% compared to the same period one year ago. After garnering initial traction in the cargo security market due to the TRACER 1000’s near-zero false alarm rate, in the second quarter, 1st Detect completed a major milestone by fulfilling its first purchase order for air...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch